We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+11.46%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$7.79B
AUM Growth
+$1.66B
Cap. Flow
+$1.24B
Cap. Flow %
15.91%
Top 10 Hldgs %
68.56%
Holding
80
New
15
Increased
18
Reduced
10
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 28.44%
2 Utilities 18.49%
3 Energy 7.97%
4 Technology 4.19%
5 Financials 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDV icon
51
Indivior Pharmaceuticals
INDV
$4.57B
$16.9M 0.22%
+1,360,000
New +$14M
SCPH
52
DELISTED
scPharmaceuticals
SCPH
$16.9M 0.22%
4,775,000
SEG
53
Seaport Entertainment Group
SEG
$375M
$16M 0.21%
573,408
+296,466
+107% +$8.54M
TSAT icon
54
Telesat
TSAT
$930M
$15.8M 0.2%
959,764
OABI icon
55
OmniAb
OABI
$497M
$10.1M 0.13%
2,850,588
FOXF icon
56
Fox Factory Holding Corp
FOXF
$911M
$10M 0.13%
+331,900
New +$11.4M
ARDX icon
57
Ardelyx
ARDX
$1.02B
$8.65M 0.11%
1,706,485
-1,353,706
-44% -$7.48M
TH icon
58
Target Hospitality
TH
$1.61B
$8.24M 0.11%
+852,505
New +$7.13M
CHRS icon
59
Coherus Oncology
CHRS
$181M
$7.26M 0.09%
5,258,754
-5,141,246
-49% -$5.77M
ABUS icon
60
Arbutus Biopharma
ABUS
$905M
$5.5M 0.07%
1,681,090
ZVRA icon
61
Zevra Therapeutics
ZVRA
$676M
$5.14M 0.07%
616,123
+596,123
+2,981% +$5.09M
MYPS icon
62
PLAYSTUDIOS Inc
MYPS
$72.8M
$5.04M 0.06%
2,711,190
RSKD icon
63
Riskified
RSKD
$847M
$5.04M 0.06%
1,066,025
-2,313,637
-68% -$10.7M
OVID icon
64
Ovid Therapeutics
OVID
$485M
$4.96M 0.06%
5,315,969
ANIP icon
65
ANI Pharmaceuticals
ANIP
$1.73B
$3.13M 0.04%
56,671
HOWL icon
66
Werewolf Therapeutics
HOWL
$18.6M
$1.97M 0.03%
1,333,893
TXMD icon
67
TherapeuticsMD
TXMD
$24.1M
$1.03M 0.01%
1,192,191
VINC
68
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$30.7K ﹤0.01%
5,844
AIR icon
69
AAR Corp
AIR
$5.99B
-471,699
Closed -$30.8M
CAR icon
70
Avis
CAR
$4.95B
-672,406
Closed -$58.9M
CSTM icon
71
Constellium
CSTM
$4B
-1,523,832
Closed -$24.8M
EXTR icon
72
Extreme Networks
EXTR
$3.21B
-3,931,913
Closed -$59.1M
FIP icon
73
FTAI Infrastructure
FIP
$535M
-3,150,352
Closed -$29.5M
GLNG icon
74
CALL
Golar LNG
GLNG
$5.2B
-700,000
Closed -$25.7M
TDOC icon
75
Teladoc Health
TDOC
$1.21B
-4,126,624
Closed -$37.9M

Similar funds

Rubric Capital Management (New York)'s Q4 2024 Portfolio in Review

As of Q4 2024, Rubric Capital Management (New York) held 80 positions worth $7.79B, up 27% from $6.14B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Rubric Capital Management (New York) deployed $1.24B of net new capital in Q4 2024, opening 15 new positions and adding to 18 existing holdings. Its largest new stake was New Fortress Energy: 15,000,000 shares worth $227M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 33% a quarter earlier, followed by Utilities and Energy.

On the sell side, the largest reduction was Talen Energy Corp, an estimated $1.02B trimmed.

  • Rubric Capital Management (New York)'s largest Q4 2024 buy was New Fortress Energy: 15,000,000 shares worth $227M.
  • Rubric Capital Management (New York) added most to QuidelOrtho in Q4 2024, an estimated $55.2M increase.
  • Rubric Capital Management (New York)'s biggest Q4 2024 reduction was Talen Energy Corp, cutting an estimated $1.02B.
  • Rubric Capital Management (New York) fully exited Vistra in Q4 2024, selling an estimated $252M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 69% of its $7.79B portfolio in Q4 2024.
  • Rubric Capital Management (New York) opened 15 new positions and closed 11 in Q4 2024.
  • Rubric Capital Management (New York)'s portfolio value rose 27% quarter-over-quarter to $7.79B.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.